Literature DB >> 17339198

Steroid treatment in children with sickle-cell disease.

Sonia Couillard, Malika Benkerrou, Robert Girot, Valentine Brousse, Alicia Ferster, Brigitte Bader-Meunier.   

Abstract

Given the controversy concerning the effects of steroids in patients with sickle cell disease (SCD), we evaluated the tolerability of long-term steroid treatment in 16 children with SCD and autoimmune and/or systemic diseases. The steroid treatment was poorly tolerated.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17339198     DOI： 10.3324/haematol.10800

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  12 in total

1.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

Review 2.  Sickle cell disease in children.

Authors:  Emily Riehm Meier; Jeffery L Miller
Journal:  Drugs       Date:  2012-05-07       Impact factor: 9.546

3.  Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell Disease.

Authors:  Deepika S Darbari; Ros S Fasano; Caterina P Minniti; Oswald O Castro; Victor R Gordeuk; James G Taylor; Jeffre Y Rehm
Journal:  J Natl Med Assoc       Date:  2008-08       Impact factor: 1.798

Review 4.  Wheezing in children with sickle cell disease.

Authors:  Jeffrey A Glassberg; Robert Strunk; Michael R DeBaun
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

Review 5.  Rheumatic Manifestations of Haemoglobinopathies.

Authors:  Michael Hughes
Journal:  Curr Rheumatol Rep       Date:  2018-08-14       Impact factor: 4.592

6.  Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.

Authors:  John J Strouse; Clifford M Takemoto; Jeffrey R Keefer; Gregory J Kato; James F Casella
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

7.  The corticosteroid compounds prednisolone and vamorolone do not alter the nociception phenotype and exacerbate liver injury in sickle cell mice.

Authors:  Luis E F Almeida; Jesse M Damsker; Sarah Albani; Nina Afsar; Sayuri Kamimura; Drew Pratt; David E Kleiner; Martha Quezado; Heather Gordish-Dressman; Zenaide M N Quezado
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

Review 8.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

9.  Rheumatoid Arthritis in Sickle-Cell Population: Pathophysiologic Insights, Clinical Evaluation and Management.

Authors:  Isabel M McFarlane; David J Ozeri; Yair Saperstein; Milena Rodriguez Alvarez; Su Zhaz Leon; Kristaq Koci; Sophia Francis; Soberjot Singh; Moro Salifu
Journal:  Rheumatology (Sunnyvale)       Date:  2017-09-12

10.  Coexistent sickle-cell anemia and autoimmune disease in eight children: pitfalls and challenges.

Authors:  Valerie Li-Thiao-Te; Florence Uettwiller; Pierre Quartier; Florence Lacaille; Brigitte Bader-Meunier; Valentine Brousse; Mariane de Montalembert
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-17       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.